RT - Journal TY - JOUR A1 - Nimbalkar, Ajay A1 - Pande, Sushil A1 - Sharma, Ramesh A1 - Borkar, Milind T1 - Tuberculin purified protein derivative immunotherapy in the treatment of viral warts YR - 2016/1/1 JF - Indian Journal of Drugs in Dermatology JO - Indian J Drugs Dermatol SP - 19 OP - 23 VO - 2 IS - 1 UL - https://www.ijdd.in/article.asp?issn=2455-3972;year=2016;volume=2;issue=1;spage=19;epage=23;aulast=Nimbalkar;t=5 DO - 10.4103/2455-3972.184103 N2 - Introduction: Viral warts are caused by human papillomavirus. Although various treatment modalities are available, many of them result in the partial clearance of warts or recurrence. Immunotherapy has been tried in the recent times with variable success rates. We undertook a study to evaluate the safety and efficacy of immunotherapy using tuberculin purified protein derivative (PPD) for the treatment of viral warts. Materials and Methods: A total of 45 patients were included in the study. Each patient was injected with 10 TU of tuberculin PPD (0.1 ml) intralesionally in the largest wart at 2 weekly interval. A total of maximum six treatment sessions were conducted. Resolution of viral warts was considered as the clinical end point of the study. The clinical assessment was done by photographic measurements at baseline, before each treatment session, and 3 weeks after the completion of treatment. Results: A total of 62.2% patients (28 out of 45) showed complete clearance at injected and distant warts, eight patients (17.8%) showed partial clearance, and nine patients (20%) showed no improvement. No significant side effects were observed except for localized hair loss around injected viral wart over the scalp. Conclusion: Tuberculin PPD immunotherapy was found to be a safe and effective treatment modality for the treatment of viral warts. ER -